Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Kifissia – page 43

1 033 clinical trials in Kifissia, Greece across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

GreeceOur site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)
Kifissia at a glance
1 033
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

1 033 trials in Kifissia

Open in trial search

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Chronic kidney disease+1

Not recruiting

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Colitis ulcerative

Not recruiting

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Study of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Seagen Inc.

Prophylaxis+1

Not recruiting

Study on the Safety of Salbutamol Inhalers with Propellants HFA-152a and HFA-134a for Adults with Asthma

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:Salbutamol Sulfate
  • Sponsor:Glaxosmithkline Research & Development Limited

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Schizophrenia

Not recruiting

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:Iclepertin
  • Sponsor:Boehringer Ingelheim International GmbH

Systemic scleroderma

Not recruiting

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Fipaxalparant
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Dermatitis atopic

Not recruiting

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Dermatitis atopic

Not recruiting

Study on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Humanised IgG1 kappa monoclonal antibody against interleukin 18
  • Sponsor:Glaxosmithkline Research & Development Limited

Other cities in Greece

The busiest research cities in the country

All 47 cities in Greece

Clinical research in Kifissia

What the registry says about research in the country

01 Oncology Research

Groundbreaking clinical trials focusing on non-small cell lung cancer and innovative treatment combinations. Studies evaluating novel therapies including immunotherapy agents and targeted treatments for various stages of cancer.

  • Advanced NSCLC Treatments
  • Breast Cancer Therapies
  • Gastrointestinal Cancer Studies

Multiple trials exploring combination therapies with chemotherapy and radiation for enhanced treatment outcomes.

02 Cardiovascular Studies

Important research in atrial fibrillation and stroke prevention, investigating new therapeutic approaches for cardiovascular conditions. Studies focusing on novel anticoagulants and heart attack treatments.

  • Stroke Prevention Therapies
  • Cardiac Rhythm Management
  • Acute Coronary Syndrome

Innovative treatments being evaluated to improve patient outcomes in emergency cardiovascular care.

03 Neurological Research

Clinical investigations targeting Alzheimer's disease and associated conditions, with a focus on managing psychosis and cognitive symptoms. Studies evaluating novel therapeutic approaches.

  • Alzheimer's Disease Treatments
  • Psychosis Management
  • Cognitive Function Studies

Dedicated research into improving quality of life for patients with neurodegenerative conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.